Literature DB >> 26173399

Heme oxygenase-1 promoter polymorphisms and risk of spina bifida.

Kazumichi Fujioka1, Wei Yang1, Matthew B Wallenstein1, Hui Zhao1, Ronald J Wong1, David K Stevenson1, Gary M Shaw1.   

Abstract

BACKGROUND: Spina bifida is the most common form of neural tube defects (NTDs). Etiologies of NTDs are multifactorial, and oxidative stress is believed to play a key role in NTD development. Heme oxygenase (HO), the rate-limiting enzyme in heme degradation, has multiple protective properties including mediating antioxidant processes, making it an ideal candidate for study. The inducible HO isoform (HO-1) has two functional genetic polymorphisms: (GT)n dinucleotide repeats and A(-413)T SNP (rs2071746), both of which can affect its promoter activity. However, no study has investigated a possible association between HO-1 genetic polymorphisms and risk of NTDs.
METHODS: This case-control study included 152 spina bifida cases (all myelomeningoceles) and 148 non-malformed controls obtained from the California Birth Defects Monitoring Program reflecting births during 1990 to 1999. Genetic polymorphisms were determined by polymerase chain reaction and amplified fragment length polymorphisms/restriction fragment length polymorphisms using genomic DNA extracted from archived newborn blood spots. Genotype and haplotype frequencies of two HO-1 promoter polymorphisms between cases and controls were compared.
RESULTS: For (GT)n dinucleotide repeat lengths and the A(-413)T SNP, no significant differences in allele frequencies or genotypes were found. Linkage disequilibrium was observed between the HO-1 polymorphisms (D': 0.833); however, haplotype analyses did not show increased risk of spina bifida overall or by race/ethnicity.
CONCLUSION: Although, an association was not found between HO-1 polymorphisms and risk of spina bifida, we speculate that the combined effect of low HO-1 expression and exposures to known environmental oxidative stressors (low folate status or diabetes), may overwhelm antioxidant defenses and increase risk of NTDs and warrants further study.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  genetic polymorphisms; heme oxygenase-1; neural tube defects; oxidative stress; spina bifida

Mesh:

Substances:

Year:  2015        PMID: 26173399      PMCID: PMC6532789          DOI: 10.1002/bdra.23343

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  32 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.

Authors:  N Yamada; M Yamaya; S Okinaga; K Nakayama; K Sekizawa; S Shibahara; H Sasaki
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects.

Authors:  T I Chang; M Horal; S K Jain; F Wang; R Patel; M R Loeken
Journal:  Diabetologia       Date:  2003-03-26       Impact factor: 10.122

4.  Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients.

Authors:  Ying-Hwa Chen; Shing-Jong Lin; Ming-Wei Lin; Hui-Ling Tsai; San-San Kuo; Jaw-Wen Chen; Min-Ji Charng; Tao-Cheng Wu; Lung-Ching Chen; Yu-An Ding; Wen-Harn Pan; Yuh-Shan Jou; Lee-Young Chau
Journal:  Hum Genet       Date:  2002-06-19       Impact factor: 4.132

Review 5.  The role of heme oxygenase-1 promoter polymorphisms in human disease.

Authors:  Markus Exner; Erich Minar; Oswald Wagner; Martin Schillinger
Journal:  Free Radic Biol Med       Date:  2004-10-15       Impact factor: 7.376

Review 6.  Regulation of heme oxygenase-1 gene transcription: recent advances and highlights from the International Conference (Uppsala, 2003) on Heme Oxygenase.

Authors:  Jawed Alam; Kazuhiko Igarashi; Stephan Immenschuh; Shigeki Shibahara; Rex M Tyrrell
Journal:  Antioxid Redox Signal       Date:  2004-10       Impact factor: 8.401

7.  Birth defects monitoring in California: a resource for epidemiological research.

Authors:  L A Croen; G M Shaw; N G Jensvold; J A Harris
Journal:  Paediatr Perinat Epidemiol       Date:  1991-10       Impact factor: 3.980

8.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

Authors:  A E Czeizel; I Dudás
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

9.  A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese.

Authors:  Koh Ono; Yoichi Goto; Shuichi Takagi; Shunroku Baba; Naomi Tago; Hiroshi Nonogi; Naoharu Iwai
Journal:  Atherosclerosis       Date:  2004-04       Impact factor: 5.162

10.  Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis.

Authors:  S Brouard; L E Otterbein; J Anrather; E Tobiasch; F H Bach; A M Choi; M P Soares
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  1 in total

Review 1.  The Role of Heme Oxygenase-1 Promoter Polymorphisms in Perinatal Disease.

Authors:  Ruka Nakasone; Mariko Ashina; Shinya Abe; Kenji Tanimura; Hans Van Rostenberghe; Kazumichi Fujioka
Journal:  Int J Environ Res Public Health       Date:  2021-03-29       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.